Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122318) titled 'Prospective Randomized Controlled Study on the Application of a Novel Antibacterial Hydrogel Dexamethasone Sustained-Release Agent Following Intraocular Surgery' on April 12.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tongji Hospital of Tongji University
Condition:
None
Intervention:
Dexamethasone eye drops standard treatment group:Dexamethasone eye drops
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-12
Target Sample Size: Dexamethasone eye drops standard treatment group:69;Antibacterial hydrogel dexamethasone sustained-release injection t...